Ad hoc: Strong increase in Result and Sales in the first Quarter 2013
Villingen-Schwenningen, 10 May 2013 NEXUS AG, specialized in medical software, was able to increase sales by 20% from KEUR 13,855 in Q1-2012 to KEUR 16,604 in Q1-2013. The operating result after taxes increased by 20.5% to KEUR 1,702 (Q1-2012: KEUR 1,413).
The sales increase in the Healthcare Software Division was 12.9% and amounted to KEUR 14,509 following KEUR 12,853 in the previous year. Sales in the Healthcare Service Division increased by approx. 109.1% in the first quarter 2013 to KEUR 2,095 (Q1-2012: KEUR 1,002). The sales of ASS.TEC GmbH and E&L medical systems GmbH consolidated for the first time contributed to part of the sale increase (12.9%).
The result before taxes improved by 18.1% to KEUR 1,662 (Q1-2012: KEUR 1,407) in comparison to the previous year, and the result after taxes increased to KEUR 1,702 following KEUR 1,413 in the previous year (+20.5%). The EBITDA increased by approx. 17.1% to KEUR 3,240 (Q1-2012: KEUR 2,767) during the reporting period.
The cash flow from on-going business transactions was at a high level at KEUR 4,547, but was lower than in the previous year (Q1-2012: KEUR 6,353). The share of international business in sales volume was 42.9% or KEUR 7,125 in the first quarter (Q1-2012: KEUR 6,952).
With approx. EUR 69.7 million equity capital, NEXUS AG has a healthy balance sheet and sufficient capital to finance further growth. Cash reserves increased by approx. KEUR 2,941 to EUR 25.9 million compared to the end of the business year (31 December 2012: EUR 23.1 million).